New cancer vaccine to stop disease before it takes hold in the body - Pharmaceutical giant GSK and the University of Oxford ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

A new cancer vaccine is being developed which scientists hope could target the disease before it takes hold. The University ...

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

The Oxford Vaccine Group is set to send five healthy people to the Netherlands to be infected with a form of malaria to allow scientists to study its effects.

When Oxford University developed the AstraZeneca vaccine, Dr Sue Pavord, a consultant haematologist, was so eager for it to ...

UK oncology researchers have come together to write the first-ever national thought leadership strategy report into cancer ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

In the study involving 33 healthy adult volunteers aged 21 to 45, scientists employed a cross-vaccination approach by administering a live-attenuated yellow fever vaccine followed by a challenge 28 ...

With no vaccines or specific treatments currently available, vigilance is key to avoiding infection of Human metapneumovirus (HMPV) is key. HMPV, according to the Cleveland Clinic, usually causes ...

The study noted an increased risk of this neurological disorder in patients who had received the Arexvy and Abrysvo vaccine from each firm respectively. As a result, the agency issued a request ...